LIPOCORE (AOD 9604 PEPTIDE) TARGETED SCIENCE FOR STUBBORN ABDOMINAL FAT

WHAT IS LIPOCORE?

LipoCore is a premium synthetic peptide introduced by JN Beauty Solutions® in April 2026, following an extensive 8-month period of research, refinement, and real-world experience.

The name LipoCore is derived from “Lipo” (referring to lipid/fat metabolism) and “Core” (emphasizing the core area of the body, particularly stubborn abdominal fat). This name represents a selective approach aimed at supporting the breakdown of excess fat and sculpting the physique, helping users achieve a firmer and slimmer body.

LipoCore (commonly known in research as AOD 9604) is a synthetic peptide consisting of 16 amino acids, developed based on the C-terminal fragment of human growth hormone (hGH). It is specifically designed to support selective lipid metabolism and promote the breakdown of excess fat, while minimizing the systemic effects typically associated with full-length growth hormone.

WHY LIPOCORE IS GAINING SIGNIFICANT ATTENTION

With the slogan “LipoCore – Targeted Science for Stubborn Abdominal Fat”, the product is attracting strong interest from physicians and aesthetic clinics due to its potential to support the reduction of stubborn abdominal fat, including both visceral fat (deep internal fat) and subcutaneous abdominal fat.

Experts consider it a scientifically selective solution that helps improve waist circumference, flatten the abdominal area, and enhance overall body composition when combined with a suitable diet and exercise regimen.

In addition to its potential for abdominal fat reduction, LipoCore also offers several other promising benefits currently under research:

  • Supports improved body composition with minimal impact on lean muscle mass.
  • Enhances metabolic flexibility without causing significant effects on blood glucose or insulin sensitivity.
  • Potential support for joint health and cartilage regeneration (based on experimental studies with localized application).

DEVELOPMENT BACKGROUND

LipoCore research began in the 1990s at Monash University in Australia. Early studies, including several Phase I/II clinical trials involving more than 900 participants, demonstrated a favorable tolerability profile. Some trials recorded mild to moderate weight loss, with a more noticeable trend in the abdominal area.

DETAILED MECHANISM OF ACTION

LipoCore primarily acts on fat cells (adipocytes) through a selective pathway focused on lipid metabolism.

Its main mechanisms include:

  • Stimulating lipolysis (fat breakdown): LipoCore helps increase the expression and sensitivity of beta-3 adrenergic receptors (β3-AR) on the surface of fat cells. Activation of these receptors initiates a signaling cascade: it raises intracellular cyclic AMP (cAMP) levels, which then activates protein kinase A (PKA). This process leads to the phosphorylation and activation of hormone-sensitive lipase (HSL) – the key enzyme responsible for breaking down stored triglycerides into free fatty acids and glycerol. These fatty acids are subsequently released into the bloodstream for oxidation and energy production.
  • Inhibiting lipogenesis (new fat formation): At the same time, LipoCore may reduce the activity of certain enzymes such as acetyl-CoA carboxylase, thereby limiting the conversion of excess calories into new fat stores. This dual action helps shift the body’s metabolism toward utilizing stored fat for energy rather than accumulating additional fat.
  • A standout advantage of LipoCore is its high selectivity. Unlike full-length human growth hormone, LipoCore DOES NOT BIND TO THE GROWTH HORMONE RECEPTOR and therefore DOES NOT STIMULATE IGF-1 PRODUCTION. It also has minimal interference with glucose metabolism or insulin sensitivity, allowing its effects to focus primarily on adipose tissue — especially the abdominal region, where β3-adrenergic receptors are highly expressed.

EVIDENCE FROM RESEARCH

Studies indicate that LipoCore has good tolerability, comparable to placebo, with no reports of serious related adverse effects. Preclinical and early clinical data suggest potential support for fat oxidation, particularly in stubborn abdominal areas. Additionally, some animal studies have noted supportive effects on cartilage regeneration when used locally.

USAGE GUIDELINES (UNDER PROFESSIONAL SUPERVISION)

LipoCore is typically administered via subcutaneous injection at a dose of 250–500 mcg per day (recommended 300 mcg once daily). However, the exact dosage and protocol should be adjusted by a physician according to each individual’s needs.

Best results are typically achieved when combined with a calorie-controlled diet and consistent exercise, especially cardio and strength training focused on the core area.

RECOMMENDED COMBINATIONS

In clinical practice, LipoCore can be flexibly combined with other peptides to create strong synergistic effects, particularly in protocols for abdominal fat reduction and body sculpting:

  • With Gluvera (GLP-1), Sylina (GLP-1 & GIP), or Trigluma (GLP-1 + GIP + Glucagon): These are among the most powerful combinations. The GLP-1/GIP/Glucagon peptides help control appetite, reduce calorie intake, and improve overall metabolism, while LipoCore directly supports fat burning at the cellular level (especially abdominal and visceral fat). This combination creates a perfect dual effect: controlling calorie input from above while enhancing fat breakdown from below.
  • With Satilyn (Amylin Analog): Enhances satiety and portion control, providing excellent support for LipoCore in maintaining long-term fat-burning processes.
  • With Regenova (CBP 157 + GHK-Cu Peptide + TB500 + KVP): This combination supports fat reduction while simultaneously promoting recovery, reducing inflammation, and tissue regeneration, helping the body recover better during weight loss and intense training.
  • With CJC-Ipamorelin: Supports natural growth hormone release, protects lean muscle mass, and enhances body sculpting effectiveness when used together with LipoCore.
  • All combinations should start with low doses and be carried out under the close supervision of an experienced physician.

DISCLAIMER

  • LipoCore is a research peptide introduced by JN Beauty Solutions®. The product has not been approved by any pharmaceutical regulatory authorities for therapeutic purposes.
  • LipoCore is intended for professional research use only.
  • All information is for reference only, based on specialized research data and publicly available studies.
  • Use must be prescribed and strictly supervised by a qualified physician. We strongly recommend consulting a doctor before applying any protocol.

CONCLUSION

LipoCore represents a significant advancement in the field of peptides for fat metabolism support, thanks to its highly selective mechanism of action. By directly stimulating lipolysis at the fat cell level — with a particular focus on the abdominal area — LipoCore offers considerable potential for weight loss programs and stubborn abdominal fat reduction protocols.

With its ability to support the breakdown of visceral fat and subcutaneous abdominal fat while having minimal impact on lean muscle mass or hormonal balance, LipoCore is an ideal choice for integration into comprehensive fat-reduction protocols. When combined with Gluvera, Sylina, Trigluma, Satilyn, Regenova, or CJC-Ipamorelin, it creates powerful synergistic effects — controlling calorie intake, enhancing localized fat burning, and supporting recovery and long-term results.

LipoCore is more than just a peptide; it is a scientifically selective solution for those seeking a modern, refined approach focused on difficult-to-reduce abdominal fat.

With its favorable tolerability profile from previous studies and high flexibility in combinations, LipoCore is emerging as a highly promising supportive tool in weight loss programs, body sculpting, and body composition improvement at specialized clinics.

For more product details, please contact:

JN Beauty Solutions®

Beauty From Science                                        

#LipoCore #TargetedScience #StubbornAbdominalFat #BellyFatReduction #VisceralFat

#WaistlineSculpting #BodyContouring #FatMetabolism #CoreSculpting #PeptideTherapy

#JNBeautySolutions